SecBot SecBot
S-1/A ·Filed May 1, 2026

NVACW

Profusa, Inc.
BEARISH
Impact 8/10
Horizonimmediate Processed5mo ago SEC0001213900-26-050904
IPO registration amendment
Actionable Insight ▼ Bearish

Avoid this stock due to imminent delisting risk and catastrophic dilution. Monitor Nasdaq hearing decision (expected within weeks) — if delisting is confirmed, equity likely becomes worthless. The ELOC floor price ($0.111) provides limited downside protection but the company has no revenue and is burning cash rapidly.

DirectionBearish
Confidencehigh
Horizonimmediate

Executive Summary

Profusa files S-1/A to register up to 179.3M shares for resale by Ascent Partners and Sponsor, including shares from a $100M ELOC and convertible notes. The company reported zero 2025 revenue, a net loss of $35.8M, and has substantial doubt about its ability to continue as a going concern. Nasdaq delisting is imminent pending appeal, making this a highly dilutive distressed capital raise.

Key Financial Metrics

Rev Growth
-100.0%

Key Facts

  • Zero revenue in 2025 vs $100K in 2024; net loss of $35.8M
  • Accumulated deficit of $160.8M as of Dec 31, 2025
  • Going concern qualification with only $1.8M cash
  • Nasdaq delisting proceedings — hearing held Apr 21, 2026, decision pending
  • Registering up to 179.3M shares for resale; 150.6M under ELOC at up to $100M capacity
  • Stock at $0.59 (Apr 30, 2026); floor price of $0.111 limits ELOC access

Financial Impact

Massive dilution — 179.3M newly registered shares vs 4.4M outstanding; potential delisting; $35.8M annual cash burn

revenuenetIncomecashdilution

Risk Factors

  • Nasdaq delisting — hearing decision pending, could be delisted within weeks
  • Substantial going concern doubt — $1.8M cash vs $22.3M current liabilities
  • Extreme dilution — 179M+ additional shares could overwhelm existing holders
  • No approved products in the U.S.; commercialization timeline uncertain
  • Material weaknesses in internal controls and complex debt/equity instruments

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001213900-26-050904
Document: ea028858301ex23-1.htm0001213900-26-050904
Document: ea028858301ex23-2.htm0001213900-26-050904
Document: 0001213900-26-050904-index-headers.html0001213900-26-050904
Document: 0001213900-26-050904-index.html0001213900-26-050904
Document: 0001213900-26-050904.txt0001213900-26-050904
10 reports for NVACW
Performance horizon
Filters
Rows
Reports for NVACW — sortable, filterable
TypeNow
Jun 8, 2026
20w ago
8-K
BEARISH ★ 6/10
—awaiting T+20——
May 26, 2026
21w ago
8-K
BULLISH ★ 5/10
—awaiting T+20——
May 15, 2026
23w ago
8-K
NEUTRAL ★ 4/10
—awaiting T+20——
May 8, 2026
24w ago
8-K
NEUTRAL ★ 4/10
—awaiting T+20——
May 1, 2026
25w ago
S-1/A
BEARISH ★ 8/10
—awaiting T+20——
Apr 29, 2026
25w ago
8-K
BEARISH ★ 7/10
—awaiting T+20——
Apr 28, 2026
25w ago
S-1
BEARISH ★ 8/10
—awaiting T+20——
Apr 27, 2026
26w ago
8-K
MIXED ★ 5/10
—awaiting T+20——
Apr 24, 2026
26w ago
8-K
BEARISH ★ 7/10
—awaiting T+20——
Apr 6, 2026
29w ago
8-K
MIXED ★ 6/10
—awaiting T+20——
Showing 10 of 10

US Market Status

Market Closed — Opens Wed (11h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026